Optimizing Comprehensive Molecular Profiling in Advanced NSCLC: A Full Circle Learning Experience to Close the Testing-to-Treatment Gap - CME - Guideline Central

CME

Title
Optimizing Comprehensive Molecular Profiling in Advanced NSCLC: A Full Circle Learning Experience to Close the Testing-to-Treatment Gap
Link
Description
Up to 40% of patients with advanced NSCLC harbor rare actionable mutations (HER2, MET, RET, ROS1, BRAF) that are never detected and, thus, never treated. Hear Dr. Ben Levy in this certified Full Circle Learning experience on how to close this gap by strengthening your ability to select the right molecular testing strategy, interpret complex NGS reports, and confidently translate rare mutation findings into evidence-based treatment decisions. Through expert microlearning, interactive patient cases, and real-time peer benchmarking, you'll build practical skills for navigating the testing-to-treatment pathway. Earn up to 2.0 CME/CE credits (AMA PRA Category 1 Credit<supTM, AAPA, ANCC) and 2.0 ABIM MOC points while gaining personalized approaches you can apply immediately in practice. Join other oncology clinicians in transforming how rare mutations are detected and treated in your patients with advanced NSCLC.
Target Audience
Hematologists and Oncologists
Learning Objectives
  • Differentiate diagnostic workflows and testing strategies to ensure comprehensive detection of rare actionable mutations in advanced NSCLC.
  • Interpret comprehensive molecular reports to identify clinically actionable rare mutations and determine therapeutic implications.
  • Implement evidence-based treatment strategies for patients with rare molecular alterations across treatment lines.
Estimated Duration
120 minutes
Delivery Mode
Online
Format
Online Learning
Specialties
Hematology, Oncology
Keywords
non-small-cell lung carcinoma (NSCLC)
Disclosures and Disclaimers
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Accredited Providers
  • Postgraduate Institute for Medicine
  • Stitched Health, Inc
Commercial Support
  • Boehringer Ingelheim Pharmaceuticals, Inc
Activity Expiration Date
March 31, 2027
Credit Information
Credit TypeUnits / Unit TypeBoard
AMA PRA Category 1 Credit2 CreditsACCME- Accreditation Council for Continuing Medical Education
AAPA Category 1 Credit2 CreditsAAPA- American Academy of Physician Associates
Nursing2 Contact HoursANCC - American Nurses Credentialing Center
You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.